Stock listing

Euronext:ALGEN genOway SA Action

Home listing (Euronext) of genOway SA

Follow genOway SA into a list and get an email when it puts out news.

Share price · EURONEXT:ALGEN

€1.91 EUR -0.05 (-2.6%)

Close on Nov 20, 2026

Past year -27.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€1.80 – €1.93 EURNov 20, 2026
Volume
65,162 sharesNov 20, 2026
Market cap
€23.57M EURAt the close on Nov 20, 2026 · price × 12.34M shares outstanding
52-week range
€1.80 – €2.88 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€18,955 EURMedian day 3,973 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
genOway SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALGEN · Home€1.91 EUR-0.05 (-2.6%)65,162€1.93€1.93€1.80€1.96Close on Nov 20, 2026
Frankfurt:JEH€1.755 EUR-0.01 (-0.6%)—€1.755€1.755€1.755€1.765Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:ALGEN · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.91-0.05-2.6%€1.93€1.93€1.8065,162
€1.960.000.0%€1.96€1.96€1.8812,531
€1.96-0.04-2.0%€2.04€2.04€1.8956,119
€2.000.000.0%€2.09€2.09€1.949,600
€2.00-0.03-1.5%€2.00€2.00€2.001,406
€2.03+0.12+6.3%€1.93€2.10€1.935,050
€1.91+0.03+1.6%€1.86€1.98€1.863,256
€1.88-0.02-1.1%€1.88€1.96€1.8519,604
€1.90-0.075-3.8%€1.975€1.975€1.8120,183
€1.975-0.02-1.0%€1.995€1.995€1.9153,699
€1.995+0.08+4.2%€2.00€2.02€1.968,820
€1.915-0.165-7.9%€2.12€2.19€1.9193,187
€2.08+0.05+2.5%€2.04€2.08€2.031,762
€2.03-0.04-1.9%€2.05€2.07€2.027,936
€2.070.000.0%€2.12€2.14€2.066,773
€2.07-0.03-1.4%€2.10€2.19€2.067,707
€2.10-0.04-1.9%€2.14€2.14€2.068,013
€2.14-0.05-2.3%€2.15€2.15€2.112,452
€2.19-0.01-0.5%€2.20€2.20€2.13869
€2.200.000.0%€2.20€2.20€2.075,963
€2.20-0.02-0.9%€2.22€2.22€2.17659
€2.22+0.02+0.9%€2.20€2.22€2.141,057
€2.200.000.0%€2.22€2.22€2.16492
€2.20+0.05+2.3%€2.17€2.20€2.1710,994
€2.15-0.02-0.9%€2.15€2.19€2.15681
€2.17-0.07-3.1%€2.09€2.19€2.095,985
€2.240.000.0%€2.24€2.26€2.24763
€2.24+0.02+0.9%€2.22€2.24€2.201,040
€2.22-0.01-0.4%€2.21€2.25€2.186,788
€2.23+0.01+0.5%€2.22€2.31€2.0220,795
€2.22-0.18-7.5%€2.40€2.42€2.1720,095
€2.400.000.0%€2.40€2.42€2.2023,004
€2.40+0.12+5.3%€2.30€2.40€2.3011,147
€2.28+0.08+3.6%€2.20€2.41€2.0133,797
€2.20-0.05-2.2%€2.23€2.23€2.0913,667
€2.25-0.09-3.8%€2.32€2.34€2.198,568
€2.34-0.02-0.8%€2.36€2.36€2.321,142
€2.36+0.02+0.9%€2.34€2.36€2.342,837
€2.34-0.02-0.8%€2.36€2.36€2.349,640
€2.36-0.04-1.7%€2.36€2.38€2.364,887
€2.400.000.0%€2.48€2.50€2.3158,604
€2.40-0.04-1.6%€2.44€2.50€2.405,522
€2.44-0.04-1.6%€2.48€2.48€2.444,883
€2.480.000.0%€2.48€2.48€2.402,810
€2.48+0.04+1.6%€2.44€2.50€2.424,727
€2.44+0.07+3.0%€2.37€2.44€2.372,688
€2.37-0.01-0.4%€2.38€2.38€2.371,094
€2.38-0.06-2.5%€2.46€2.46€2.384,387
€2.44-0.03-1.2%€2.44€2.44€2.441,408
€2.47-0.03-1.2%€2.50€2.50€2.471,007
€2.500.000.0%€2.50€2.50€2.46821
€2.50+0.03+1.2%€2.47€2.50€2.47212
€2.47-0.01-0.4%€2.50€2.50€2.47800
€2.480.000.0%€2.49€2.50€2.483,010
€2.48-0.02-0.8%€2.50€2.50€2.481,527
€2.50-0.02-0.8%€2.50€2.50€2.461,604
€2.52+0.06+2.4%€2.46€2.53€2.461,070
€2.46-0.02-0.8%€2.44€2.46€2.403,938
€2.48+0.01+0.4%€2.47€2.49€2.46263
€2.47+0.01+0.4%€2.46€2.50€2.464,008
€2.46+0.01+0.4%€2.45€2.46€2.45196
€2.45-0.01-0.4%€2.46€2.46€2.441,996
€2.46+0.02+0.8%€2.46€2.46€2.441,760
€2.44-0.02-0.8%€2.46€2.51€2.441,250
€2.46+0.01+0.4%€2.45€2.46€2.444,288
€2.450.000.0%€2.45€2.45€2.411,875
Ticker
Euronext:ALGEN
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Euronext
Currency
EUR

Latest news

All genOway SA news

genOway SA on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
5 in all · newest Sep 22, 2025 · oldest 2016
Decks
5 decks · latest Sep 24, 2025

Where genOway SA is listed

ListingExchangeCountryCurrency
Euronext:ALGEN · Home listing · This pageEuronextFranceEUR
gettex:JEHgettexGermanyEUR
LS Exchange:A0MRJ4LS ExchangeGermanyEUR
Dusseldorf:JEHDusseldorfGermanyEUR
Frankfurt:JEHFrankfurtGermanyEUR
Lang & Schwarz:A0MRJ4Lang & SchwarzGermanyEUR
Munich:JEHMunichGermanyEUR
Stuttgart:JEHStuttgartGermanyEUR
Turquoise:ALGENPTurquoiseUnited KingdomEUR

Valuation

P/E 25.4× against a median of 7.9×: the highest of 3 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
€35.49M EUR
P/E
25.4×
EV/sales
1.7×
EV/EBITDA
8.7×
Price/book
1.1×
Gross margin
48.9%
Operating margin
3.2%
Net margin
4.4%
Debt to equity
0.7×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
genOway SA · EURONEXT:ALGENUS$25.87MUS$38.95M25.4×1.7×8.7×1.1×4.4%0.7×n/a
MedMira Inc. · TSXV:MIRUS$26.92MUS$27.23Mn/a105×n/an/a−808.2%n/a0.29
BIOQUAL, Inc. · OTC:BIOQUS$26.83MUS$42.28Mn/a1.1×n/a0.8×−11.0%1.0×-0.01
Ikonisys SA · EURONEXT:ALIKOUS$26.75MUS$31.11Mn/a20.4×n/a1.3×−302.8%0.3×n/a
Interpace Biosciences, Inc. · OTC:IDXGUS$26.56MUS$23.63M1.2×0.6×21.0×1.1×58.1%0.0×-0.33
Microbix Biosystems Inc. · TSX:MBXUS$26.27MUS$25.96Mn/a2.4×n/a1.6×−31.7%0.3×0.03
Bioptic Inc. · TPEX:6850US$26.11MUS$22.55Mn/an/an/a2.0×n/a0.2×n/a
Orientbio, Inc. · KRX:002630US$25.03M−US$3.27M14.6×−0.1×−0.8×0.5×8.1%0.0×n/a
Clever Culture Systems Limited · ASX:CC5US$24.62MUS$25.47Mn/a8.3×n/a4.9×−48.4%0.4×n/a
CLEO Diagnostics Ltd · ASX:COVUS$24.57MUS$20.44Mn/an/an/a7.4×n/a0.0×n/a
Genesystem Co., Ltd. · KRX:363250US$24.54MUS$22.35Mn/a29.8×n/a2.8×n/a0.2×n/a
Median of the othersUS$26.19MUS$24.55M7.9×5.4×10.1×1.6×−31.7%0.2×0.01

Team and board

Officers

OfficerRole
Alexandre FraichardFounder and General Manager

Board

DirectorRole
Christian GrenierChairman of the board
Alexandre FraichardFounder and General Manager
Jean-Louis MenardAdministrator
Olivier CharmeilAdministrator
Patrick BlainAdministrator
Raffy KazandjianAdministrator

Events

QuarterResultsShare move
Q2 2025Sep 24, 2025+8.2%
Quarter to Mar 31, 2025Apr 29, 2025+0.7%
Q3 2022Oct 17, 2022+0.4%
Q2 2022Jul 18, 2022+2.1%
Q2 2021Sep 27, 2021−5.0%
Q1 2021Jun 23, 2021−1.1%

Open Events

Decks

DeckKindSlidesDate
Investor Day (September 2025)Investor day89 slidesSep 24, 2025
FY2023 Earnings PresentationEarnings15 slidesMar 26, 2024
Investor Presentation (January 2024)Investor deck23 slidesJan 16, 2024
Investor Presentation (September 2022)Investor deck21 slidesSep 27, 2022
Non-Deal Roadshow (October 2019)Roadshow23 slidesOct 31, 2019

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue21.0M22.1M20.0M17.1M14.0M11.0M14.3M15.0M13.2M11.5M
Cost of revenue10.7M12.8M1.24M18.4M17.8M14.0M6.12M6.34M5.79M4.95M
Gross profit10.2M-1.89M18.8M-1.31M-3.75M-2.96M8.16M8.61M7.38M6.58M
Selling, general and administrative19.7M17.0M15.1M14.6M12.9M11.3M6.38M5.21M9.03M
Operating income669.4K1.81M2.07M949.8K-4.59M-3.84M-575.1K579.8K753.8K691.9K
Depreciation and amortization3.41M2.97M4.29M2.74M1.92M1.30M1.18M847.0K620.9K339.1K
EBITDA4.08M4.78M6.35M3.69M-2.67M-2.54M605.1K1.43M1.37M1.03M
Interest expense307.6K146.5K109.1K122.0K274.7K173.0K246.2K448.5K154.6K124.5K
Income before tax1.25M-1.96M1.55M758.9K-4.08M-4.04M-973.2K549.2K1.93M553.3K
Income tax-10.2K-3.79M-20.0K-2.70M-3.75M76.5K63.2K22.4K-2.52M-28.9K
Net income928.0K1.83M1.57M777.8K-322.6K-687.3K-1.04M571.6K1.93M582.2K
Earnings per share, basic0.070.190.170.09-0.04-0.10-0.180.100.320.10

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents549.3K4.95M4.26M4.88M5.61M2.72M1.09M3.05M3.95M2.64M
Short-term investments6.50M523.4K-36.3K-36.3K739739
Receivables9.86M7.01M5.60M13.6M6.36M5.35M4.04M2.75M2.57M3.38M
Inventory994.1K1.09M982.8K1.19M1.03M1.20M676.4K544.5K469.1K738.2K
Current assets22.9M17.5M17.7M19.8M19.3M14.5M9.77M10.2M10.6M10.3M
Property, plant and equipment5.56M5.88M6.67M7.17M7.87M5.83M6.25M5.63M482.8K
Goodwill197.0K197.0K197.0K197.0K197.0K197.0K196.9K196.9K196.9K196.9K
Total assets45.4M31.8M31.8M32.9M32.5M27.6M19.2M19.7M17.2M11.7M
Accounts payable2.81M2.89M2.58M2.62M2.22M2.29M2.39M2.25M771.5K1.41M
Current liabilities7.29M8.60M8.39M6.99M6.45M7.94M6.59M5.62M5.40M6.15M
Long-term debt12.5M4.14M5.52M9.04M8.99M10.0M5.26M4.66M3.73M0
Total debt13.8M5.58M7.23M9.05M10.8M10.8M6.02M4.67M4.18M10.7K
Total liabilities20.4M13.2M14.5M16.8M17.9M18.6M12.3M11.8M9.98M6.44M
Shareholders' equity25.0M18.6M17.4M16.2M14.7M9.00M6.84M7.89M7.19M5.26M
Shares outstanding12.5M9.48M9.03M8.82M8.82M6.78M5.86M5.87M5.94M5.95M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-1.43M5.38M3.06M2.36M-561.3K-164.3K1.18M847.0K620.9K-901.8K
Capital spending-10.9M-2.39M-1.78M-1.92M-2.28M-4.52M-2.70M-2.70M-2.70M-254.5K
Free cash flow-12.4M2.99M1.28M438.6K-2.84M-4.68M1.18M847.0K620.9K-1.16M
Cash from investing-11.3M-2.86M-2.00M-1.94M-2.26M-4.75M-4.75M-4.75M-4.75M-241.7K
Cash from financing14.8M-1.83M-1.69M-1.14M5.71M6.54M6.54M6.54M6.54M0
Share buybacks-101.5K-73.0K01.22M637.5K2.69M00
Change in cash2.10M698.1K-621.8K-727.3K2.88M1.63M-1.96M-894.7K1.31M-1.14M

Open Financials

Cap table

Built by 6ix from genOway SA’s releases

Common shares
12,338,532
Fully diluted
12,338,532

Fully diluted

LineShares
Common shares12,338,532

Share count over time

CountShares
Nov 22, 202612,338,532

Open Cap table

Shareholders

InsiderTradeSharesPriceValueDate
Alexandre Fraichard
DG
Buy14,691EUR 2.03EUR 29,773Nov 10, 2026
Alexandre Fraichard
DG
Buy4,539EUR 2.10EUR 9,547Oct 30, 2026
Alexandre Fraichard
DG
Buy18,100EUR 2.17EUR 39,215Oct 23, 2026
Alexandre Fraichard
DG
Buy13,750EUR 2.16EUR 29,762Oct 10, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alexandre FraichardFounder and General Manager · Since at least Nov 5, 2026
Christian GrenierChairman of the board · Since at least Nov 5, 2026
Jean-Louis MenardAdministrator · Since at least Nov 5, 2026
Olivier CharmeilAdministrator · Since at least Nov 5, 2026
Patrick BlainAdministrator · Since at least Nov 5, 2026
Raffy KazandjianAdministrator · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about genOway SA.